News

Published on 1 Sep 2022 on Bloomberg via Yahoo Finance

Novo Nordisk to Buy Forma Therapeutics in $1.1 Billion Deal


Article preview image

(Bloomberg) -- Novo Nordisk A/S agreed to buy Forma Therapeutics Holdings Inc. in a deal valuing the US biotech company at about $1.1 billion, as it seeks to expand its reach in treatments for rare blood disorders.

Most Read from Bloomberg

Lukoil Chairman Ravil Maganov Dies After Falling From Hospital WindowPutin Brings China and India to Russia for War Games Defying USJeremy Grantham Warns ‘Super Bubble’ in Stocks Has Yet to BurstUS Jobs Data Have Potential to Push Fed Toward Third Jumbo Hike

NYSE.NVO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly,...

FEATURE For pharmaceutical companies’ stock prices, there are few events as crucial as the result...

Barrons.com 1 Jan 2025

Historical Trends Warrant a Closer Look at Novo Nordisk (NVO) Call Options

As TipRanks’ Vince Condarcuri stated, NVO stock has slipped significantly due to a string of bad...

TipRanks · via Yahoo Finance 31 Dec 2024

Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by...

Insider Monkey · via Yahoo Finance 31 Dec 2024

Lilly and Novo Went Head-to-Head Over Weight-Loss Drugs in 2024. There’s a Clear...

Despite ever-increasing sales, Eli Lilly stock is down 13% in the fourth quarter, while Novo’s...

Barrons.com 31 Dec 2024

Is Novo Nordisk A/S (NVO) the Best Pharma Dividend Stock to Buy In 2024?

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article...

Insider Monkey · via Yahoo Finance 30 Dec 2024

Here’s Why Novo Nordisk A/S (NVO) Slid in Q3

Loomis Sayles, an investment management company, released its “International Growth Fund” third q...

Insider Monkey · via Yahoo Finance 27 Dec 2024

...Have Fewer Side Effects And Be More Effective’ - Novo Nordisk (NYSE:NVO), Eli...

An endorsement of a weight-loss drug by world's richest man Elon Musk could prove beneficial in t...

Benzinga 26 Dec 2024

Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?

On Dec. 20, the bull thesis for Novo Nordisk stock took a massive hit. In terms of its financial...

Motley Fool · via Yahoo Finance 26 Dec 2024

Jim Cramer Says Novo Nordisk A/S (NVO) Can’t Exceed Eli Lilly

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In...

Insider Monkey · via Yahoo Finance 25 Dec 2024

Novo Nordisk Stock Plunges 18% in a Week: What Should Investors Do?

Novo Nordisk’s failure favors its arch-rival in the obesity market space, Eli Lilly...treatment. ...

Zacks · via Yahoo Finance 24 Dec 2024